LONDON (AP) – A British drug regulator is urging people to continue taking AstraZeneca coronavirus vaccines despite revelations that seven people in the UK have died from a rare blood clot after being bitten.
The Drug Enforcement Agency, or MHRA, said it was unclear whether the shootings caused blood clots, that it was “an ongoing study of rare, specific blood type tissue in UK reports.”
Although the agency reported late Friday that seven people had died from a blood clot, it did not provide any information on their age or health.
In all, the MHRA said it had identified 30 rare cases of blood clots out of AstraZeneca’s 18.1 million doses delivered as of March 24. The risk of this type of blood clot is “very small”.
“The benefits of the COVID-19 vaccine AstraZeneca in the prevention of COVID-19 infection, its complications continue to outweigh any risk, and the public should continue to receive the vaccine when invited,” said Dr. June Un Raine, CEO of the agency.
Concerns about the AstraZeneca vaccine have already prompted some countries, including Canada, France, Germany and the Netherlands, to limit its use for the elderly. The UK, which has developed faster coronavirus vaccines than other European countries, is particularly dependent on the AstraZeneca vaccine, developed by scientists at Oxford University.
The MHRA’s view on the relative benefits of the vaccine is shared by the European Medicines Agency. It says the causal link between the unusual clots in people who have received the vaccine is “not proven, but it is possible” that the benefits of the vaccine outweigh the risks of side effects. The World Health Organization has also urged countries to continue using the cavity.
Adam Finn, a professor of pediatrics at the University of Bristol, says the “extreme rarity” of blood clots in the context of millions of strokes in the UK makes the decision very clear.
“Getting the vaccine is by far the safest choice in terms of minimizing the risk of serious illness or death,” he said.
A closer look at the results of the MHRA shows that 22 out of 30 cases were associated with cerebral venous sinus thrombosis, which stops the brain from stopping bleeding properly, and eight were associated with other cases of low platelet thrombosis.
It states that there are no reports of blood clots around the Pfizer / BioNTech vaccine, which are widespread in the UK.
Follow the AP Epidemic Coverage: